Course Director:
Manju T. Beier, Pharm..D., FASCP
President, Geriatric Consultant Resources, LLC
Clinical Assistant Professor, College of Pharmacy
University of Michigan, Ann Arbor, Michigan, USA

Upon completion of this program, the participant should be able to:

1. Describe the epidemiology of heart failure in the geriatric population.

2. Discuss the pathophysiologic mechanisms involved in heart failure and the effects of aging on cardiac function.

3. Recognize the signs and symptoms of heart failure in an elderly patient.

4. Outline the importance of determining the etiology of heart failure and the role of specific diagnostic tests, including imaging studies,

5. Understand the role of angiotensin-converting enzyme inhibitors (ACEIs), diuretics, digoxin, vasodilators, beta-blockers and angiotensin II receptor antagonists in the pharmacologic management of heart failure due to left ventricular systolic dysfunction.

6. Enumerate the highlights (design elements and results) of the pivotal clinical trials incorporating pharmacotherapy for the management of heart failure.

Target Audience
Geriatric health-care practitioners

Accreditation
At this time we are offering CE for pharmacists only. The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

First Release Date: June 1998
Second Release date: July 2002
Expiration Date: July 2005

This program (Program {INDIVIDUAL PROGRAM NUMBER #203-999-02-605-H01)} qualifies for 0.175 CEUs (1.75 contact hours) of continuing pharmacy education. CEUs will be awarded provided that the participant reviews this site and scores 70% or better on the post test that follows. To receive a statement of credit, please complete the examination and evaluation that follows this program. A statement will be awarded and mailed to you within 4-6 weeks.

The information provided in these programs is intended solely for the continuing educational needs of health-care practitioners. The medications discussed in these programs have Food and Drug Administration approval in the US. Individuals should not exclusively rely upon the information provided in these programs.

The continuing education programs are offered "as is." Geriatric Consultant Resources, LLC disclaims all warranties and representations, express or implied, with respect to the programs and the information contained therein, including without limitation any and all warranties of title, non infringement, merchantability, or fitness for any particular purpose. Without limiting the foregoing, Geriatric Consultant Resources LLC shall not be responsible for any inaccuracy or omission in the information contained in the programs, and shall have no liability whatsoever of any kind resulting from any claim or action arising out of the use of the programs.